In a phase 2 trial investigating the effects of liraglutide in mild Alzheimer's dementia, 204 participants received either liraglutide or placebo for 12 months, with the finding that the liraglutide-treated group had significantly better cognitive function and higher cortical volume compared to control [19]
One parsimonious model is that SLC25A40 maintains ISC stability within Complex I-III, permitting controlled, signal-level ROS for transcriptional programs
BPC-157 is studied in laboratory models involving gastrointestinal biology, musculoskeletal tissue research, endothelial function, inflammatory signaling, extracellular matrix remodeling, vascular biology, and neuroscience
Patients who are pregnant, planning pregnancy, breastfeeding, or dealing with certain medical conditions may need a different approach
It is important to distinguish between an expiration date and a beyond-use date (BUD), as they serve different purposes in clinical safety
Continuation of treatment will depend on documented clinical benefit and an acceptable safety profile